Ultrasound-Triggered Drug Release and Enhanced Anticancer Effect of Doxorubicin-Loaded Poly(D,L-Lactide-Co-Glycolide)-Methoxy-Poly(Ethylene Glycol) Nanodroplets

Ultrasound in Medicine and Biology

Volumn 37, Issue 8, 2011, Pages 1252-1258

  Du, Lina ^a   Jin, Yiguang ^a,b   Zhou, Wenying ^a,b   Zhao, Jingyu ^c  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b HENAN UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Doxorubicin; Micelles; Nanodroplets; Perfluoropentane; PLGA mPEG; Ultrasound

Indexed keywords

ANTI-CANCER DRUG DELIVERY; ANTICANCER EFFECTS; DOXORUBICIN; DRUG RELEASE; ENCAPSULATION EFFICIENCY; GROUP III; NANO-DROPLETS; NANOBUBBLES; NANOPARTICULATE SYSTEM; PERFLUOROPENTANE; PLGA-MPEG; POLY(D ,L-LACTIDE-CO- GLYCOLIDE); POLYMERIC MICELLE;

DRUG DELIVERY; ENCAPSULATION; ETHYLENE; GLYCOLS; MICELLES; MOTION PICTURE EXPERTS GROUP STANDARDS; ORGANIC POLYMERS; POLYETHYLENE GLYCOLS; TUMORS;

ULTRASONICS;

COPOLYMER; DOXORUBICIN; MACROGOL; NANOBUBBLE; NANODROPLET; NANOPARTICLE; PERFLUOROPENTANE; POLYGLACTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG RELEASE; HIGH TEMPERATURE; HUMAN; HUMAN CELL; MICELLE; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; THERMOSTABILITY; TUMOR VOLUME; TUMOR XENOGRAFT; ULTRASOUND;

ANIMALS; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HYDROGEN-ION CONCENTRATION; LACTIC ACID; MICE; MICELLES; NANOPARTICLES; NEOPLASMS, EXPERIMENTAL; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; ULTRASONICS;

EID: 79959858809     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2011.05.012     Document Type: Article

References (34)

1. Amiji M.M. Nanotechnology for cancer therapy 2007, Taylor & Francis-CRC Press, Boca Raton, FL.
2. Anderson J.M., Shive M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997, 28:5-24.
3. Athanasiou K.A., Niederauer G.G., Agrawal C.M. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996, 17:93-102.
4. Avgoustakis K., Beletsi A., Panagi Z., Klepetsanis P., Livaniou E. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int J Pharm 2003, 259:115-127.
5. Avgoustakis K., Beletsi A., Panagia Z., Klepetsanisa P., Karydasb A.G., Ithakissios D.S., Evangelatos G., Ithakissios D.S. PLGA-mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release 2002, 79:123-135.
6. Blanco M.D., Sastre R.L., Teijon C., Olmo R., Teijon J.M. Degradation behaviour of microspheres prepared by spray-drying poly(d, l-lactide) and poly(d, l-lactide-co-glycolide) polymers. Int J Pharm 2006, 326:139-147.
7. Dijkmans P.A., Juffermans L.J.M., Musters R.J.P., van Wamel A., ten Cate F.J., van Gilst W., Visser C.A., de Jong N., Kamp O. Microbubbles and ultrasound: From diagnosis to therapy. Eur J Echocardiogr 2004, 5:245-256.
8. Du L., Cheng J., Chi Q., Qie J., Liu Y., Mei X. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist. Chem Pharm Bull 2006, 54:1259-1265.
9. Frenkel V. Ultrasound mediated delivery of drugs and genes to solid tumors. Adv Drug Deliv Rev 2008, 60:1193-1208.
10. Gao Z., Fain H., Rapoport N. Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J Control Release 2005, 102:203-221.
11. Gao Z., Kennedy A.M., Christensen D.A., Rapoport N.Y. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics 2008, 48:260-270.
12. Hernot S., Klibanov A.L. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 2008, 60:1153-1166.
13. Ishida T., Harashima H., Kiwada H. Liposome clearance. Biosci Rep 2002, 22:197-224.
14. Iyer A.K., Khaled G., Fang J., Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 2006, 11:812-818.
15. Jeong B., Windisch C.F.J., Park M.J., Sohn Y.S., Gutowska A., Char K. Phase transition of the PLGA-g-PEG copolymer aqueous solutions. J Phys Chem B 2003, 107:10032-10039.
16. Katsikogianni G., Avgoustakis K. Poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanoparticles: Drug loading and release properties. J Nanosci Nanotech 2006, 6:3080-3086.
17. Kim J.Y., Song M.G., Kim J.D. Zeta potential of nanobubbles generated by ultrasonication in aqueous alkyl polyglycoside solutions. J Colloid Interface Sci 2000, 223:285-291.
18. Lathia J.D., Leodore L., Wheatley M.A. Polymeric contrast agent with targeting potential. Ultrasonics 2004, 42:763-768.
19. Li Y., Pei Y., Zhang X., Gu Z., Zhou Z., Yuan W., Zhou J., Zhu J., Gao X. PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats. J Control Release 2001, 71:203-211.
20. Liu J., Levine A.L., Mattoon J.S., Yamaguchi M., Lee R.J., Pan X., Rosol T.J. Nanoparticles as image enhancing agents for ultrasonography. Phys Med Biol 2006, 51:2179-2189.
21. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev 2001, 53:283-318.
22. Primeau A.J., Rendon A., Hedley D., Lilge L., Tannock I.F. The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors. Clin Cancer Res 2005, 11:8782-8788.
23. Qiu Y., Luo Y., Zhang Y., Cui W., Zhang D., Wu J., Zhang J., Tu J. The correlation between acoustic cavitation and sonoporation involved in ultrasound-mediated DNA transfection with polyethylenimine (PEI) in vitro. J Control Release 2010, 145:40-48.
24. Rapoport N., Gao Z., Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 2007, 99:1095-1106.
25. Senthilkumar M., Mishra P., Jain N.K. Long circulating PEGylated poly(d, l-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors. J Drug Target 2008, 16:424-435.
26. Shortencarier M., Dayton P., Bloch S., Schumann P., Matsunaga T., Ferrara K. A method for radiation-force localized drug delivery using gas-filled lipospheres. IEEE Trans Ultrason Ferroelectr Freq Control 2004, 51:822-831.
27. Singal P.K., Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998, 339:900-905.
28. Suzuki R., Takizawa T., Negishi Y., Utoguchi N., Maruyama K. Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology. Int J Pharm 2008, 354:49-55.
29. Suzuki R., Takizawa T., Negishi Y., Utoguchi N., Maruyama K. Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology. Int J Pharm 2008, 354:49-55.
30. Unger E.C., Porter T., Culp W., Labell R., Matsunaga T., Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev 2004, 1291-1314.
31. Uziely B., Jeffers S., Isacson R., Kutsch K., Wei-Tsao D., Yehoshua Z. Liposomal doxorubicin: Antitumor activity and unique toxicities during two complementary phase I studies. J Clin Oncol 1995, 13:1777-1785.
32. Wang B., Siahaan T., Soltero R. Drug delivery: Principles and applications 2005, John Wiley & Sons, Inc., New York.
33. Yoo H.S., Park T.G. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J Control Release 2001, 70:63-70.
34. Yoo H.S., Park T.G. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release 2004, 96:273-283.